These results are highly consistent since they were obtained in independent laboratories, using several Ewing sarcoma cell lines (TC71, EWS502, and A673) and different gene knockdown technologies (i.e., transient retrovirus infection or inducible expression of EWS/FLI1 shRNAs). The gene discussed is EWSR1; the disease is Ewing sarcoma.